MedPath

Pelvic floor muscle training with surface electromyography

Not Applicable
Completed
Conditions
Pelvic floor muscle function
Musculoskeletal Diseases
Registration Number
ISRCTN92265528
Lead Sponsor
Gdansk University of Physical Education and Sport
Brief Summary

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30761019 results 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32028397 results (added 07/02/2020) 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31478796/ results in future exercise professionals (added 04/02/2022) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34414979/ results of high-impact aerobics programme (added 04/02/2022) 2021 Results article in https://doi.org/10.1007/s11062-021-09902-8 results of one-time biofeedback EMG session (added 04/02/2022) 2018 Results article in https://pubmed.ncbi.nlm.nih.gov/30106065/ sEMG training results (added 04/02/2022) 2018 Results article in https://doi.org/10.1007/s11062-018-9740-4 training-related changes in EMG activity (added 04/02/2022) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/36248694/ conducted as part of this study: influence of one-time biofeedback electromyography session (added 03/09/2024) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35627446/ Conducted as part of this study: Improving the Technique of Pelvic Floor Muscle Contraction (added 06/09/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
638
Inclusion Criteria

1. Women at the age of 18-45 years old (including pregnant women; nulliparous, primiparous or multiparous)
2. Health condition allows for physical activity
3. Availability to implement 6-week training program

Exclusion Criteria

1. History of pelvic-floor disorders
2. History of urogenital tract dysfunctions
3. Complicated pregnancy during the study
4. Any contraindications to physical activity

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Pelvic-floor muscle function is measured using the TeleMyo™ 2400T Direct Transmission System (DTS), NORAXON EMG and Sensors System (Scottsdale, AZ, USA) at baseline and 6 weeks.<br><br>Added 16/04/2018:<br>2. The lif eimpact of urinary incontinence symptoms is assessed using the Incontinence Impact Questionnaire at baseline and 6 weeks.
Secondary Outcome Measures
NameTimeMethod
Technique of the pelvic-floor muscle contraction is determined using a electromyography (EMG) data at baseline and 6 weeks.
© Copyright 2025. All Rights Reserved by MedPath